← Back to patent-cliff list
雷米普利
Tier C — Watch / tradeRamipril
辉瑞
Originator
1991
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ACE
Brand：Ramace、Triatec、Carasel、Unipril、Delix、Tritace、瑞泰、Altac
Indications (approved)：高血压、肾病、心肌梗塞、心脏衰竭、中风
Regional status
US
临床二期
2000-06-01
EU
终止
2006-10-01
China
批准上市
2000-12-15
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ramipril?
Approved indications include: 高血压, 肾病, 心肌梗塞, 心脏衰竭, 中风.
When does the Ramipril patent expire?
No public expiry year is available for Ramipril yet; this page updates once verified.
How do I get a quote for Ramipril intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25